CN Patent

CN117801047B — 神经甾体衍生物及其用途

Assigned to HUNAN MINGRUI PHARMACEUTICAL CO Ltd · Expires 2024-12-20 · 1y expired

What this patent protects

本发明提供具有式(I)所示结构的神经甾体衍生物及其用途。与现有技术相比，本发明所提供的具有式(I)所示结构的神经甾体衍生物具有显著更高的生物利用度，可通过非静脉给药途径给药用于治疗和/或预防GABA‑A受体介导的疾病。

USPTO Abstract

本发明提供具有式(I)所示结构的神经甾体衍生物及其用途。与现有技术相比，本发明所提供的具有式(I)所示结构的神经甾体衍生物具有显著更高的生物利用度，可通过非静脉给药途径给药用于治疗和/或预防GABA‑A受体介导的疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN117801047B
Jurisdiction
CN
Classification
—
Expires
2024-12-20
Drug substance claim
No
Drug product claim
No
Assignee
HUNAN MINGRUI PHARMACEUTICAL CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.